Discussion: In addition, functional studies demonstrated that the
E350G E6 variant has biological advantages over the E-P (European-Prototype).
Discussion: The higher association of AA and
E350G variants and cancer risk may be linked to a better ability to evade the host immune system and/or an increased oncogenic potential associated with intrinsic biological properties of viral proteins.